Anabolic. Adjuvant treatment for wasting and senile diseases, for negative calcium, phosphorus, and potassium balances, for fracture healing, osteomalacia, and rickets.

Description:

Each mL BOLDENONA-Erma® contains: Boldenone Undecylenate 50 mg.

• It stimulates the formation of red blood cells (erythropoiesis) by activating the erythropoiesis-stimulating factor.
• It is used in the recovery of bone surgeries and after fractures, to stimulate the formation of bone callus.
• Useful for debilitating diseases and fractures. Weight restoration in wasting diseases and rickets.
• It helps alleviate stress processes due to early weaning, castration and parasitism.
• It promotes tissue building and prevents cell catabolism. It contributes to improved bone growth and muscle mass development.
• Stimulates the development of male sexual characteristics (androgenic potency).
• The anabolic effect is due to the retention of Nitrogen, Potassium, Phosphorus and Calcium, which in therapeutic doses translates into weight gain, due to increased protein synthesis and greater bone and muscle development.

Deep intramuscular.

Bovines, equines, ovines and porcines: 1 mL/90 kg of body weight (equivalent to 5.5 mg per 10 kg of body weight), repeat every 2-4 weeks according to needs and a good diet. Canines: 0.25 mL/5 kg of body weight (equivalent to 50 mg per 10 kg of body weight), repeat every 2-4 weeks, depending on the animal’s response.

WITHDRAWAL PERIOD: Treated animals should not be slaughtered for human consumption until 30 days after the end of treatment. Do not apply to animals producing milk for human consumption.

Do not apply to pregnant females due to possible masculinization. Do not apply to animals with prostate carcinoma, malignant tumors, or anal adenoma.

Precautions:

In young animals, it may cause premature ossification. Use in breeding animals and the duration of treatment are at the discretion of the veterinarian. Sold under the veterinarian’s prescription.

Excessive doses may inhibit spermatogenesis by negative feedback on FSH.

Presentation:

Bottle: 250 ml.

Bovine, Canine, Equine, Ovine and Porcine.

DOSAGE :
Bovines and equines 200 mg (equivalent to 1 ml) for every 350 to 400 kg of body weight. Pigs, sheep and goats 50 mg (equivalent to 0.25 ml) for every 90 to 100 kg of body weight.

In very depressed, underweight animals or those that have suffered from some disease, a double concentration can be used, corresponding to doubling the dose in ml according to body weight for therapeutic indications.

ROUTE OF ADMINISTRATION : Deep Intramuscular

WARNINGS :
FOR VETERINARY USE ONLY
. KEEP OUT OF REACH OF CHILDREN.
CONSULT YOUR VETERINARIAN.

Long-Acting Anabolic

Formulation

Boldenone undecylinate 5 g, Slow-release vehicle and excipients 100 mL.

Indications

Due to its anabolic action, it is indicated to achieve an increase in weight gain, by increasing the efficiency in food conversion in adult or developing animals.

– Greater development of bone structure and increase in muscle mass and body weight.

– Better and greater protein synthesis, mineral retention, improved appetite and feed conversion.

– Anemic processes (by stimulation of erythropoiesis: formation of red blood cells).

– As an adjuvant in cases of osteomalacia, osteoporosis, leukopenia.

– As an adjuvant in wasting or debilitating diseases that cause weight loss, convalescent states, senile weakness, rickets, fractures (to promote the formation of bone callus) and stress situations (post-surgery, weaning, dehorning, castrations, changes of environment and prolonged summers or winters, among others).

– States of protein catabolism caused by continuous use of corticosteroids (osteoporosis-asthenia-muscle atrophy).

– Any other situation in which it is required to promote protein synthesis.

Dosage and Administration

The recommended route is deep intramuscular, according to the following dose:

Equines and cattle: 1 mL for every 90 kg of weight, every 30 days or at the discretion of the veterinarian.

For the application of doses greater than 10 mL, it is recommended to divide it into two injection sites.

Commercial Presentation

Bottles: 50 ML.